Program for Health Systems Improvement

Features
Interview with John Rowe

Leveraging Genomics to Reduce Disparities


Project Updates
HRSA Funding HIT Toolkit

HMS Longwood Seminar on Local Reform

   
Winter 2007

John Rowe: Why Collecting Racial and Ethnic Data Will Improve Health Care

Since 2002, Aetna Corporation has boldly walked where many insurers feared going. Led down this path by departing CEO and Chairman John Rowe, MD, the insurer has spent the past four years collecting data on the race and ethnicity of its members. The effort has been described as "courageous" by some and "racist" by others. Rowe, who is about to assume a job as health policy professor at Columbia University's Mailman School of Public Health, recently spoke to PHSI on why self-reporting information on race and ethnicity is an important step to narrow health care disparity gaps.

Q: What led Aetna to start collecting this data?

JR: I came to Aetna from academic medicine. I was president of Mt. Sinai Hospital and School of Medicine so I was very familiar with the issue of racial and ethnic disparities and the importance of cultural competence.

When I arrived, I realized that while we knew a lot about our members, we did not know their race or ethnicity. It turned out that no large insurance company was collecting information on this. I began to question how Aetna can make programs available to its members at high risk if we lack the data to know who is at high risk.

Q: How challenging was it for Aetna to seek out this kind of data?

JR: I was warned that this was the "third rail" of health insurance politics. There was a lot of initial resistance internally, with company staff issuing admonishments. If you started collecting this kind of data, staff warned that Aetna would be suspected of disadvantaging some of its members and feared it would be perceived as a racist company. My response to those concerns was that when a health plan knows that these groups are at special risk and does nothing about it, then it is perpetuating a racist policy.

A key experience that led to our decision was our involvement with Katie Couric's colorectal cancer screening program. It turned out that people of different races are at different risks for cancer. That tipped the scales and we began to collect data in 2002, coinciding with the release of the Institute of Medicine's landmark report on unequal treatment. That report really put a spotlight on this issue, and that was helpful to us when we went around and talked with customers.

Q: So what have you learned and what have you developed as a result?

JR: The programs we've developed include a pre-term labor program. African American women have consistently higher rates of premature birth rates than white women. When a health plan knows you are African American, it can provide additional educational materials and have nurses call you, monitor you, and enroll you in programs to avert pre-term labor. But a plan can't tell just by your name that you are African American. We need to have you report that information to us. We have other programs dealing with hypertension and cervical cancer. Vietnamese women are at high risk for cervical cancer and we have a program where we will pay for Pap smears for members at high risk. So if race or ethnic background constitutes a special risk, knowing this information permits us to identify those who are at special risk for specific conditions and target educational programs to them.

Q: Is Aetna the only health plan doing this?

JR: When we rolled this program out, there was a front page article about it in the Wall Street Journal and we got national attention. Afterwards, the federal government started a program called The National Health Plan Collaborative that brought together a dozen large health plans on how to collect data and how to use the data. Many health plans are now doing this, which I think is great. I feel that Aetna played a role in moving the field forward.

Q: This has been a voluntary strategy. Do you think self-identification should be mandatory?

JR: The literature is replete with evidence of racial and ethnic disparities. But it would be a mistake to mandate the reporting of this information. The insurance industry needs a longer track record of collecting this data without any untoward reactions. The people at Aetna were at no risk when we were collecting this data. Since it was primarily through large group insurance, there was no fear of medical underwriting.

Q: How do you collect the data?

JR: There are two ways to collect data. One is through individual reporting, and the other way is through geocoding. Geocoding uses Census data. It is not quite as good as individual reporting but if you have a large population of patients, it can help. If I was talking to a male whose last name is Wong living in Chinatown, I might assume that he is Chinese but if it's a woman, I can't assume anything. She could be married to a Chinese person but she may not be Chinese. Most health plans do both geocoding and collecting on individuals.

Q: How have you built public trust to get customers to report this information?

JR: Many of our customers are large companies/employers who are very interested in having their employees report this information. A lot of employees who are racial or ethnic minorities are not getting access to care they should be getting and paying the same premium. For business leaders that is a persuasive argument to urge employees to report this kind of information.

Q: Do you think you've made a difference? In what way?

JR: I think we have made a difference. This is a competitive business and to whatever extent people see this as a positive step, everyone will copy it. Some customers will criticize companies for not doing this.

Second, this isn't all we're doing. I required every clinician at Aetna to participate in cultural competency training. About 1,500 nurses and doctors were required to take a course on cultural competency, a skill they never learned in medical or nursing school. Massachusetts General Hospital under the leadership of Joe Betancourt has developed a course for our employees and other health plans are interested in such courses.

Q: If the data are proprietary, how much will it do for the greater public good?

JR: For proprietary reasons, we can't let others have access to our data but we can let them know how the collection is going, how much it costs to collect this data, and which groups respond less than others. Essentially, we can teach them about the perils and pitfalls of collecting data. If there was a nationalized effort we can inform how it might be structured.



How Can Genomics Research Help Improve Health and Reduce Disparities?

Can the dynamic field of genomics research guide health policy researchers who are looking to improve the health of vulnerable populations and reduce health disparities? That's what the new Harvard/MGH Center for Genomics, Vulnerable Populations and Health Disparities is hoping to accomplish over the next several years. The newly established Center, based at the Partners/MGH Institute for Health Policy and and affiliated with the Harvard Interfaculty Program for Health Systems Improvement, brings together genomics researchers, physicians, behavioral scientists, health policy researchers, philosophers, economists, and environmental scientists to address the many intersections of genomics research and concerns about the health of vulnerable populations.

Through its work, the Center seeks to educate physicians and patients about genomics research, conduct research on highly prevalent chronic diseases where genomics research holds the greatest potential for improving health, and make policy recommendations aimed at facilitating the translation of emerging genomics research into clinical practice. "We are trying to anticipate challenges and identify solutions in this fast-paced and exciting field. Our goal is to leverage emerging genomics research to improve population health, with a particular focus on the impact of genomic medicine on vulnerable and underserved populations," says Center Director Alexandra Shields, Ph.D.

The Center was created through a three-year $560,000 planning grant from the National Human Genome Research Institute with additional support from Harvard University and Partners Healthcare. The Center will focus in particular on such diseases as asthma, smoking and diabetes, where advances in treatment and prevention facilitated by genomics research could have a significant impact on population health and on reducing disparities. Currently funded projects of the Center include a national survey of primary care physicians to understand physicians' willingness to offer new genetic tests within their practice, as well as a national survey of black and white Americans to understand differences in attitudes and beliefs regarding the role of genetics in addiction. This study will also assess smokers' willingness to undergo genetic testing to be matched to the optimal smoking treatment.

The Center is also working on strategies for tracking the diffusion of available genetic tests throughout the healthcare system and is developing projects focused on accelerating gene-environment interaction research to develop new tools to address asthma disparities. Faculty from the Medical School, Faculty of Arts and Sciences, School of Public Health and the Broad Institute are currently involved in the Center's ongoing research activities, with new collaborations underway in the development of a proposal to establish an NIH Center of Excellence in Ethical Legal and Social Implications of Human Genome Research. For more information, see http://cgvh.harvard.edu/index.shtml

Project Updates
HRSA Funding HIT Toolkit for Safety Net Providers

Stimulated by a national meeting on health IT and community health centers convened by PHSI in November 2005, the federal government's Health Resources & Services Administration (HRSA) is funding the development of an HIT toolkit for safety net providers. Community health centers (CHCs), rural and HIV clinics and programs aimed at mothers and children serve about 1 in five Americans yet they lack the capital dollars to invest in HIT to help them provide better and more efficient care. As a result, the majority of these providers have been slow to adopt HIT. The goal of the Web-based toolkit is to avert a serious digital divide by helping safety net providers or providers that serve special populations better evaluate their organizational capacity to use HIT and the HIT options that are best suited for the CHC environment, and link them to tangible examples of usable tools they can access to meet their needs in their daily professional lives. The project is being coordinated with the Agency for Healthcare Research and Quality and its National Resource Center for Health Information Technology. The project began in October 2006. Researchers expect to have a final product by October 2007. For more information contact HRSA's Office of Health Information Technology at slumsden@hrsa.gov.


HMS Longwood Seminar on Local Reform

PHSI has been selected to present one of this year's Longwood Seminars sponsored each spring by Harvard Medical School for the public. The March 14, 2007 program will focus on local health systems reform including a framework for thinking about local reform, a national overview of local initiatives and an update on plans for health insurance reform in Massachusetts.

 
 

For more information on the projects and events described in this newsletter, or to unsubscribe, please contact us at phsi@harvard.edu.